One-year follow-up of newly diagnosed irritable bowel syndrome patients

Alimentary Pharmacology and Therapeutics

Volumn 13, Issue 8, 1999, Pages 1097-1102

  Ruigomez A ^a,c   Wallander, M A ^b   Johansson, S ^b   Garcia Rodriguez L A ^a  

^a Ctro Espanol de Metrologia   (Spain)

^b ASTRAZENECA R AND D   (Sweden)

^c Ctro Espanal de Investigacion F   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIDIARRHEAL AGENT; ANXIOLYTIC AGENT; LAXATIVE; SPASMOLYTIC AGENT;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; DATA BASE; DIGESTIVE SYSTEM FUNCTION DISORDER; FEMALE; HEALTH CARE; HOSPITALIZATION; HUMAN; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEX DIFFERENCE; SMOKING;

ADULT; AGED; COHORT STUDIES; COLONIC DISEASES, FUNCTIONAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PREGNANCY; RETROSPECTIVE STUDIES; RISK FACTORS; SWEDEN; TREATMENT OUTCOME;

EID: 0032815893     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1999.00576.x     Document Type: Article

References (16)

1. 1 Woodley MC, Rubin DC. Gastroenterologic diseases. In: Ewald GA, McKenzie, eds. Manual of Medical Therapeutics, 28th edn. Boston: Little, Brown and Company, 1995: pp. 361.
2. 2 Jones R, Lydeard S. Irritable bowel syndrome in the general population. Br Med J 1992; 304: 87-90.
3. 3 Thompson WG, Dotevall G, Drossman DA, Heaton KW, Kruis W. Irritable bowel syndrome: guidelines for the diagnosis. Gastroenterol Int 1989; 2: 92-5.
4. 4 Talley NJ, Zinsmeister AR, Melton LJ III. Irritable bowel syndrome in a community: symptoms subgroups, risk factors, and health care utilisation. Am J Epidemiol 1995; 142: 76-83.
5. 5 Sandler RS, Drossman DA, Nathan HP, McKee DC. Symptom complaints and health care seeking behaviour in subjects with bowel dysfunction. Gastroenterology 1984; 87: 314-18.
6. 6 Jick H, Jick SS, Derby LE. Validation of information recorded on general practitioner based computerised data resource in the United Kingdom. Br Med J 1991; 302: 766-8.
7. 7 Jick H, Terris BZ, Derby LE, Jick SS. Further validation of information recorded on a general practitioner based computerised data resource in the United Kingdom. Pharmacoepidemiol Drug Safety 1992; 1: 347-9.
8. 8 Hollewell J. General Practice Research Database: scope and quality of data. London: Office for Population Censuses and Surveys, 1994.
9. 9 Maxwell PR, Mendall MA, Kumar D. Irritable bowel syndrome. Lancet 1997; 350: 1691-5.
10. 10 Talley NJ, Phillips SF, Melton LJ, Mulvihill C, Wiltgen C, Zinsmeister AR. Diagnostic value of the Manning criteria in irritable bowel syndrome. Gut 1990; 31: 77-81.
11. 11 Kay L, Jørgensen T, Jensen KH. The epidemiology of irritable bowel syndrome in a random population: prevalence, incidence, natural history and risk factors. J Intern Med 1994; 236: 23-30.
12. 12 Thompson WG. Gender differences in irritable bowel symptoms. Eur J Gastroenterol Hepatol 1997; 9: 299-302.
13. 13 Owens DM, Nelson DK, Talley NJ. The irritable bowel syndrome: long-term prognosis and the physician-patient interaction. Ann Intern Med 1995; 122: 107-12.
14. 14 Mustard CA, Kaufert P, Kozyrskyi A, Mayer T. Sex differences in the health care services. N Engl J Med 1998; 338: 1678-83.
15. 15 Talley NJ. Why do functional gastrointestinal disorders come and go? Dig Dis Sci 1994; 39: 673-7.
16. 16 Arnalich F, Martínez-Hernández PL, Capitán CF, Camacho J. Tratamiento de la dispepsia funcional y del sindrome del intestino irritable. Inf Ter Sist Nac Salud 1998; 22: 1-8.